Inspire Medical Systems, Inc. (INSP)
Summary
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.
Here's Why You Should Add INSP Stock to Your Portfolio Now
Inspire Medical's Inspire V adoption, clinical evidence and underpenetrated OSA market support growth despite coding and reimbursement headwinds.
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?
Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support patience as reimbursement issues weigh on procedures.
Inspire Medical Systems, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 799 | $41,374.68 | $41,723.78 | $349.1 | 0.84% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 6,533 | $270,139.55 | $393,025.28 | $122,885.73 | 45.49% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 194 | $37,577.35 | $11,471.22 | -$26,106.13 | -69.47% |
| NA Nizar Araji National Bank Of Canada /FI/ | 70 | $8,182.94 | $4,211.2 | -$3,971.74 | -48.54% |
| BG Bart Gancher Intech Investment Management LLC | 21,255 | $1.1M | $1.28M | $182,367.9 | 16.63% |
Inspire Medical Systems, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| KH Keith Hinton Freedom Capital Markets | 916.4 | $41,659.32 | $47,625.05 | $5,965.73 | 14.32% |
Inspire Medical Systems, Inc. (INSP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Inspire Medical Systems, Inc. ever had a stock split?
Inspire Medical Systems, Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Timothy Herbert CEO | NYSE Exchange | 457730109 CUSIP |
| US Country | 1,333 Employees | - Last Dividend | - Last Split | 3 May 2018 IPO Date |
Overview
Inspire Medical Systems, Inc. is a pioneering medical technology company that has set its sights on developing and bringing to market minimally invasive solutions specifically designed for individuals suffering from obstructive sleep apnea (OSA). With operations spanning both the United States and international markets, Inspire Medical Systems has carved out a niche in addressing the challenges faced by patients with moderate to severe OSA. Since its establishment in 2007, the company has been headquartered in Golden Valley, Minnesota, where it continues to innovate in the medical field with a keen focus on enhancing patient care through its advanced technologies.
Products and Services
- Inspire System
The Inspire System stands as the flagship offering from Inspire Medical Systems, Inc., embodying the company’s commitment to innovation in the treatment of obstructive sleep apnea (OSA). This state-of-the-art neurostimulation technology provides a revolutionary and effective treatment method for patients classified with moderate to severe OSA. It operates by delivering mild stimulation to key airway muscles during sleep, thereby ensuring the airway remains open and mitigating the risks associated with OSA. The system represents a significant leap forward in OSA management, offering patients a safe alternative to traditional treatment modalities.
- Closed-Loop Solution
In its relentless pursuit of excellence, Inspire Medical Systems, Inc. is also developing a novel, groundbreaking closed-loop solution aimed at enhancing the care and management of OSA patients. This innovative approach involves a continuous monitoring system that vigilantly tracks a patient's breathing patterns throughout the night. In response to detected anomalies such as interrupted breathing, the system intelligently administers mild hypoglossal nerve stimulation. This stimulation is delicately calibrated to ensure the patient's airway remains open during sleep, thereby preventing the occurrence of apnea episodes. This closed-loop solution exemplifies the company's forward-thinking approach in harnessing technology to address the complexities of sleep apnea.
